The availability of anti-IL-5 mAbs has directed attention towards eosinophils as the main target of asthma treatment, neglecting the central role of IgE in SAA despite increasing awareness of the role of IgE in allergic inflammation. The gene discussed is IGHE; the disease is asthma.